health-025-May-2023 Related News
Developing mRNA vaccine technology
Following the unprecedented development of vaccines during the COVID-19 pandemic, we spoke to Dinah Knotts about mRNA vaccine technology and what further opportunities it...
Reframing the narrative about population ageing
Population ageing is a natural part of demographic development, so why is it increasingly seen as a burden?
We discuss population ageing with Joan Costa-i-Font,...
The albumin-to-creatinine ratio: shining a light on early kidney disease
Abbott outlines how albumin-to-creatinine ratio measurement can be leveraged to address the increasing global burden of kidney disease.
Albumin-to-creatinine ratio (ACR) is known to be...
Using peracetic acid in biofilm management
In response to increasing links between outbreaks and contaminated drains, GAMA Healthcare explores emerging evidence which supports the use of peracetic acid in the...
Pulsar Helium: Unmatched high-grade helium supply for the medical industry
With the helium shortage affecting MRI and respiratory gases, Pulsar Helium’s high-grade asset provides hope for the medical industry's helium supply.
Last year the American...
A boost for NervGen’s spinal cord injury trials
Following the success of its phase I clinical trial, NervGen will initiate a phase Ib/IIa trial as early as Q3 this year to demonstrate...
Health Europa Quarterly Issue 25
Welcome to Health Europa Quarterly Issue 25, where you will discover the latest health research addressing global health policy, antimicrobial resistance, medical technology, disease management,...
Towards the legalisation of medical cannabis in France
Following the launch of a medical cannabis trial to examine how the drug could be prescribed and dispensed legally, Lorna Rothery spoke to Benjamin-Alexandre...